Neurology

The assistant professor in the department of neurology at Mount Sinai discussed distinguishing cognitive impairment…

Pooled safety data of delandistrogene moxeparvovec, a gene transfer therapy for Duchenne muscular dystrophy, suggests…

The professor of neurology at University of Colorado School of Medicine talked about the challenges…

Findings from a phase 2 study of nomlabofusp, a novel investigational therapy for Friedreich ataxia,…

Despite advancements in NMOSD treatments, the founder and executive director of the Sumaira Foundation discussed…

Results from a recent phase 3 study presented at the 2025 MDA Conference reported that…

Here's some of what is coming soon to NeurologyLive® this week.: Source: Neurology Read More

Despite facing mental health concerns with anger, aggression, or irritability, among others, slightly less than…

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of…

The phase 2 CANYON trial findings presented at the 2025 MDA conference highlight sevasemten’s potential…